Uncategorized
FDA Hopes to Keep Pharma Honest With “Bad Ad” Program
Last week, the FDA unveiled its “Bad Ad” program to encourage physicians to report questionable pharmaceutical sales pitches.
Look Ma, No Pain: Treating Asymptomatic Patients
It’s not hard to convince a patient who is in pain to take his or her medication, but what about the patient who doesn’t feel any symptoms?
Dodd’s Bill: Harmful to Medical Device Start-Ups?
A financial reform bill currently moving through the Senate is causing a furor among businesspeople and investors, with experts predicting that the bill will harm innovation in America.
Mobile Apps Help Patients Manage Their Medications
Some of the most popular techniques for medication management may fall short when patients are on the go.
The Interoperability Issue: Making EMRs Play Well With Others
Interoperability is one of the biggest barriers to the widespread adoption of EMRs.
Enhanced Provider Directories Match Patients Up with Doctors
With the new healthcare reform bill, about 30 million people are about to need doctors.
FDA, Clinical Trial News: $ABIO, $GENZ, $KV-A, $SLXP
Shares of ARCA Biopharma (NASDAQ:ABIO) are soaring today on news of an issued patent that includes the methods of treating heart failure patients with Gencaro (bucindolol) based on genetic testing.